MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors
Experimental and Clinical Endocrinology & Diabetes · 01.05.2024 · 132 (05) · 240-248
DOI: 10.1055/a-2268-4129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.05.2024. Verfasst von Emiliya Nikolova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Chemistry and Biochemistry, Medical University-Sofia, Sofia, Bulgaria. Hauptthemen laut MEDLINE: Pituitary Neoplasms, MicroRNAs, Neoplasm Invasiveness, Neuroendocrine Tumors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Medical University Sofia.
Abstract (Originalsprache)
Purpose
This preliminary study aimed to analyze and identify differentially expressed miRNAs in Bulgarian patients with non-functioning pituitary neuroendocrine tumors (NFPitNET). The relationship between deregulated miRNAs and tumor invasiveness, recurrence, and size was determined.
Methods
Twenty patients with NFPitNET were selected and fresh pituitary tumor tissues were collected. RNA containing miRNAs were isolated using miRNAeasy mini kit and analyzed by quantitative real-time polymerase chain reaction (PCR) using LNA miRNA Cancer-Focus PCR Panel (Qiagen).
Results
Three miRNAs (miR-210-3p, miR-149-3p, and miR-29b-3p) were deregulated in invasive compared to non-invasive NFPitNETs. Differential expression of four-miRNA signatures – miRNA-17, miR-19, miR-106a, and miR-20, correlated with patient recurrence.
Conclusion
This prospective pilot study selected a unique miRNA expression profile, that correlates with invasiveness and recurrence in non-functioning pituitary neuroendocrine tumors. Moreover, some of the selected miRNAs are reported for the first time in patients with this disease, shedding light on the molecular mechanisms involved in pituitary pathogenesis. The identified miRNAs demonstrate potential as biomarkers, deserving further investigation in a larger cohort to validate their clinical applicability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Chemistry and Biochemistry, Medical University-Sofia, Sofia, Bulgaria.
- Department of Endocrinology, Medical University-Sofia, USHATE "Acad. Ivan Penchev", Sofia, Bulgaria.
- Department of Neurosurgery, Medical University-Sofia, University Hospital "St. Ivan Rilski" Sofia, Bulgaria.
- National Genetic Laboratory, Medical University- Sofia, UHOG "Maichin dom", Sofia, Bulgaria.
- Genetic and Medico-diagnostic Laboratory "Genica", Sofia, Bulgaria.
ORCID-Profile: Atanaska Elenkova
Förderung
- Medical University Sofia
Zitieren
APA
Nikolova, E., Nankova, A., Kalenderova, S., Georgieva, B., Hadzhiyanev, A., Bichev, S., Savov, A., Todorova, A., Mitev, V., & Elenkova, A. (2024). MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors. Experimental and Clinical Endocrinology & Diabetes, 132(05), 240-248. https://doi.org/10.1055/a-2268-4129
Vancouver
Nikolova E, Nankova A, Kalenderova S, Georgieva B, Hadzhiyanev A, Bichev S, et al. MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors. Experimental and Clinical Endocrinology & Diabetes. 2024;132(05):240-248. doi:10.1055/a-2268-4129
BibTeX
@article{Nikolova2024,
author = {Nikolova, Emiliya and Nankova, Anelia and Kalenderova, Silvia and Georgieva, Bilyana and Hadzhiyanev, Asen and Bichev, Stoyan and Savov, Alexey and Todorova, Albena and Mitev, Vanyo and Elenkova, Atanaska},
title = {MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2024},
volume = {132},
number = {05},
pages = {240--248},
doi = {10.1055/a-2268-4129}
}
EUVIMED